Public and Private Entities Share Knowledge to Promote the Cannabis Industry in Argentina

Public and private institutions and civil societies exchanged knowledge to promote the articulation and boost the development of cannabis and industrial hemp at a meeting convened by the National Agri-Food Health and Quality Service (Senasa).

“We are opening doors; first the medicinal aspect of cannabis was opened and now we are working for its industrial use”, highlighted the president of Senasa, Diana Guillén, when opening today, together with the Secretary of Agriculture, Juan José Bahillo, the First Interinstitutional Meeting for the Development of Cannabis and Industrial Hemp.

Read more on the subject and find the latest market updates with the Hemp.im mobile app. The application organizes what’s happening in the cannabis world to help you learn more about the stories that matter to you. Stay informed with the latest hemp news and get the important information in one application.

The meeting, which is being held at the “Nestor Kirchner” Cultural Center (CCK), will address the innovations and regulatory updates needed to support the country’s producers

After highlighting Senasa’s competencies “in the formulation of phyto-zoophytosanitary and food safety standards” related to hemp cultivation, Guillén considered it “necessary that the work is done jointly and interinstitutional from the portfolios of Health, Production, and Agriculture.”

For his part, Bahillo -who spoke at the end of the opening ceremony- acknowledged the former Minister of Agriculture, Luis Basterra, and Guillén (at that time Chief of Cabinet of the agricultural portfolio) for promoting Resolution 140 that “initiated the end of the prohibitionism of the hemp industry and it was possible to start working on the development of the sector.”

He also pointed out that currently “four species of cultivars are registered and another five are about to be approved” by the National Seed Institute (Inase).

He also praised Senasa’s initiative that “based on Law 27.699 promoted an Interinstitutional Roundtable for the Development of Cannabis and Industrial Hemp” and stated “the strong commitment of the State to support the growth of this sector that will benefit regional economies, with sustainable production and formal employment”.

Also present at the inauguration were the vice-president of Senasa, Rodolfo Acerbi, the national director of Animal Health, Ximena Melón; the president of Inase, Silvana Babbit and the director of the Institute of Biological Resources of the National Institute of Agricultural Technology (INTA), Silvina Lewin, among other officials.

The meeting, which is being broadcast on Senasa’s official channel on Youtube, brings together, in addition to Senasa, professionals and technicians from Sagpya, INTA, Inase, the National Institute of Industrial Technology (INTI), the Ministry of Health, Anmat, Conicet, Inaes and the Faculty of Agronomy of the University of Buenos Aires, as well as representatives of civil associations such as Mamá Cultiva Argentina and Proyecto Cáñamo.

The meeting, which will continue this Tuesday, October 25th, includes topics such as History, memories, and progress of the different experiences related to medical cannabis and industrial hemp; Regulatory frameworks and experiences: a view from the State and organizations; Legislation and research: correct reading and interpretation of the regulations established for the production, use, and research of medical cannabis and industrial hemp; and Projects and developments of the national industry: strengthening of industrial processes, organizations involved in the production chain.

__

(Featured image by Jess Loiterton via Pexels)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in telam DIGITAL, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.